148 related articles for article (PubMed ID: 10865045)
21. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?
Weaver DL; Vacek PM; Skelly JM; Geller BM
Ann Surg Oncol; 2005 Aug; 12(8):660-73. PubMed ID: 15968496
[TBL] [Abstract][Full Text] [Related]
22. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography.
Lee JM; Abraham L; Lam DL; Buist DSM; Kerlikowske K; Miglioretti DL; Houssami N; Lehman CD; Henderson LM; Hubbard RA
J Clin Oncol; 2018 Jul; 36(20):2070-2077. PubMed ID: 29718790
[TBL] [Abstract][Full Text] [Related]
23. [Long follow-up of breast cancer revealed by clustered microcalcifications without palpable mass].
Wehbe G; Sepanda M; Nos C; Falcou MC; Meunier M; Zafrani B; Fourquet A; Durand JC; Azoury J; Massoud E; Bentley Clough K
J Med Liban; 2004; 52(1):2-7. PubMed ID: 15881694
[TBL] [Abstract][Full Text] [Related]
24. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study.
Tabár L; Chen HH; Duffy SW; Yen MF; Chiang CF; Dean PB; Smith RA
Lancet; 2000 Feb; 355(9202):429-33. PubMed ID: 10841122
[TBL] [Abstract][Full Text] [Related]
25. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening.
Tabar L; Chen HH; Duffy SW; Krusemo UB
Jpn J Clin Oncol; 1999 Dec; 29(12):608-16. PubMed ID: 10721943
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
27. Mammographic findings of recurrent breast cancer after lumpectomy and radiation therapy: comparison with the primary tumor.
Philpotts LE; Lee CH; Haffty BG; Lange RC; Tocino I
Radiology; 1996 Dec; 201(3):767-71. PubMed ID: 8939229
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association].
Fourneret P; Artignan X; De Cornulier J; Pasquier D; Panh MH; Payan R; Kolodié H; Vincent F; Fric D; Bernard P; Colona M; Bolla M
Cancer Radiother; 2006 Dec; 10(8):550-8. PubMed ID: 16890006
[TBL] [Abstract][Full Text] [Related]
29. Mammographic features of local recurrence after conservative surgery and radiation therapy: comparison with that of the primary tumor.
Günhan-Bilgen I; Oktay A
Acta Radiol; 2007 May; 48(4):390-7. PubMed ID: 17453518
[TBL] [Abstract][Full Text] [Related]
30. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts.
Hungness ES; Safa M; Shaughnessy EA; Aron BS; Gazder PA; Hawkins HH; Lower EE; Seeskin C; Yassin RS; Hasselgren PO
Surgery; 2000 Oct; 128(4):702-7. PubMed ID: 11015105
[TBL] [Abstract][Full Text] [Related]
31. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
Kerlikowske K; Barclay J; Grady D; Sickles EA; Ernster V
J Natl Cancer Inst; 1997 Jan; 89(1):76-82. PubMed ID: 8978410
[TBL] [Abstract][Full Text] [Related]
32. Treatment uncertainties surround early diagnosis of breast cancer.
Vanchieri C
Ann Intern Med; 1997 Apr; 126(8):I53-4. PubMed ID: 9446506
[No Abstract] [Full Text] [Related]
33. [The role of preoperative hooked-wire localization of occult lesions for early detection of breast cancer].
Szabo-Moskal J; Lasek W; Kozłowska R; Sir J; Serafin Z
Ginekol Pol; 2005 Jan; 76(1):15-9. PubMed ID: 15844561
[TBL] [Abstract][Full Text] [Related]
34. Independent prognostic value of screen detection in invasive breast cancer.
Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
[TBL] [Abstract][Full Text] [Related]
35. Ductal carcinoma in situ.
Loring L; Dershaw DD
Crit Rev Diagn Imaging; 1997 Dec; 38(6):501-33. PubMed ID: 9442977
[TBL] [Abstract][Full Text] [Related]
36. Specimen-orientated radiography helps define excision margins of malignant lesions detected by breast screening.
Dixon JM; Ravi Sekar O; Walsh J; Paterson D; Anderson TJ
Br J Surg; 1993 Aug; 80(8):1001-2. PubMed ID: 8155117
[TBL] [Abstract][Full Text] [Related]
37. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.
Ernster VL; Barclay J
J Natl Cancer Inst Monogr; 1997; (22):151-6. PubMed ID: 9709292
[TBL] [Abstract][Full Text] [Related]
38. [Surgical treatment of nonpalpable mammographic abnormalities using guidewire localization].
Ben Aharon U; Lifscitz O; Strano SD; Mavor E; Barzilai N
Harefuah; 1995 Feb; 128(4):205-7, 264. PubMed ID: 7744325
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and treatment of breast cancers 10 mm or less detected by a mammographic screening programme.
Kitchen PR; Cawson JN; Winch KL; Henderson MA
Aust N Z J Surg; 1998 Jan; 68(1):45-9. PubMed ID: 9440456
[TBL] [Abstract][Full Text] [Related]
40. Invasive breast cancer: mammographic measurement.
Flanagan FL; McDermott MB; Barton PT; Pilgram TK; Dehdashti F; Wick MR; Monsees BS
Radiology; 1996 Jun; 199(3):819-23. PubMed ID: 8638011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
